For research use only. Not for therapeutic Use.
CJ-13,610(Cat No.:I006146)is a potent and selective antagonist of the prostaglandin D2 (PGD2) receptor subtype DP1. By blocking DP1 receptor activation, CJ-13,610 inhibits PGD2-mediated signaling involved in allergic inflammation, bronchoconstriction, and immune cell recruitment. It has been used extensively in preclinical models to study the role of PGD2 in conditions such as asthma, allergic rhinitis, and other inflammatory diseases. CJ-13,610 helps elucidate DP1 receptor function and supports the development of anti-inflammatory therapies targeting prostaglandin pathways. Its high specificity makes it a valuable pharmacological tool for immunology and respiratory research.
CAS Number | 179420-17-8 |
Synonyms | 4-[3-[4-(2-methylimidazol-1-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide |
Molecular Formula | C22H23N3O2S |
Purity | ≥95% |
IUPAC Name | 4-[3-[4-(2-methylimidazol-1-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide |
InChI | InChI=1S/C22H23N3O2S/c1-16-24-11-12-25(16)18-5-7-19(8-6-18)28-20-4-2-3-17(15-20)22(21(23)26)9-13-27-14-10-22/h2-8,11-12,15H,9-10,13-14H2,1H3,(H2,23,26) |
InChIKey | VPTONMHDLLMOOV-UHFFFAOYSA-N |
SMILES | CC1=NC=CN1C2=CC=C(C=C2)SC3=CC=CC(=C3)C4(CCOCC4)C(=O)N |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |